Learn more from OA experts

Jeffrey Rosen, MD
Orthopaedic Surgeon
New York University Medical Center

Stanley Dysart, MD Orthopaedic Surgeon


JR: The projected cause of arthritis to society and the numbers that are increasing over the next 20 years are largely attributed to the growing and aging baby boomer population.

SD: its more dynamic than that. Yes, aging is a risk factor for arthritis but there are other risk factors that are very common such as obesity, such as trauma and there is a large genetic component to the disease. And I say disease with the thought previously there was a wear and tear process but that is not very accurate, its actually a disease process that affects all aspects of the joint and there are multiple causes.

JR: The knee joint is one of the most commonly affective joints that people come into an orthopaedics office complaining about arthritis related pain. And the primary reason is we don't give our knees a rest, we are on our knees all day, everyday.

SD: it is subject to multiple stresses during the day and also gets major stresses in the form of injury and other disease processes

JR: We think about carrying our body weight around but when you add physics equations to the problem, getting in and out of a chair, running up and down the stairs or jumping up and down on your knees, actually you are carrying multiples of your body weight around; five times, ten times your body weight depending upon the activity that you are doing. So that a weight gain of 10 pounds on the knee joint could be equivalent to 100 pounds of extra weight carried on the knees depending upon the level of activity that you are performing.

More Webcasts

EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used in people who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.

Important Safety Information
You should not receive this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products. You should not have an injection into the knee if you have a knee joint infection or if you have skin disease or infection around the injection site.

EUFLEXXA is only for injection into the knee performed by a qualified doctor. After you receive this injection you may need to avoid activities such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour). The safety and effectiveness of repeat treatment cycles of EUFLEXXA have not been established. The safety and effectiveness of EUFLEXXA have not been shown in people under 18 years of age.

Side effects sometimes seen when EUFLEXXA is injected into the knee joint were pain, swelling, skin irritation, and tenderness and these were generally mild and did not last long.

Please see Full Prescribing Information.

Please see Important Information for Patients.

Patient Treatment Information

PLEASE CONSULT WITH YOUR DOCTOR, OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL BEFORE USING ANY PRODUCT DISCUSSED WITHIN THIS WEB SITE.

This website is intended only for US residents.

Euflexxa® is a registered trademark of Ferring Pharmaceuticals Inc.